Progesterone in Menopausal Hormone Therapy: Endometrial Protection, Dosing, Benefits, and Risks
- Feb 3, 2025
- 3 min read
Updated: 2 days ago
Related service information: Hormone Therapy
For a woman with an intact uterus who uses systemic estrogen, an adequate progestogen is generally required to reduce the risk of estrogen-induced endometrial hyperplasia and endometrial cancer. Progesterone should not be promoted as a proven treatment for depression, generalized anxiety, skin rejuvenation, collagen production, bone building, or weight control.
Why the Uterine Lining Needs Protection
Systemic estrogen stimulates the endometrium. When estrogen is used without adequate opposition in a woman who still has a uterus, the lining may become excessively thick and can progress to hyperplasia or cancer. Adding an effective progestogen substantially reduces that risk.
This is the main evidence-based reason progesterone is paired with systemic estrogen. A woman who has undergone hysterectomy usually does not need a progestogen for endometrial protection, although individual circumstances may justify a different plan.
Progesterone and Progestins Are Related but Not Identical
Micronized progesterone is chemically identical to endogenous progesterone. Synthetic progestins activate the progesterone receptor but have different pharmacologic properties. Both can provide endometrial protection when an evidence-based product, dose, and schedule are used.
The term bioidentical does not mean risk-free or inherently superior. FDA-approved micronized progesterone is available. Compounded creams and other nonstandard products may have variable absorption, and transdermal compounded progesterone should not be assumed to provide reliable endometrial protection.
Common Oral Regimens
Common regimens include oral micronized progesterone 100 mg nightly on a continuous schedule or 200 mg nightly for 12 to 14 days each month on a cyclic schedule. These examples are not interchangeable prescriptions. The appropriate regimen depends on the estrogen dose and route, bleeding pattern, menopausal stage, tolerance, and medical history.
Cyclic therapy commonly produces scheduled withdrawal bleeding. Continuous therapy is often selected after menopause to reduce planned bleeding, although irregular bleeding may occur during the first months. Any persistent, heavy, recurrent, or new postmenopausal bleeding requires evaluation rather than automatic dose escalation.
What Benefits Are Reasonably Expected
The established benefit is endometrial protection during systemic estrogen therapy. Oral micronized progesterone is sedating for some patients and may improve sleep in selected women, but it should not be represented as a universal sleep medication.
Evidence is insufficient to market progesterone as a stand-alone treatment for major depression, generalized anxiety, cognitive decline, skin aging, collagen loss, osteoporosis, or metabolic weight gain. Menstrual regulation in perimenopause is a separate clinical use that depends on the cause of abnormal bleeding and requires appropriate evaluation.
Side Effects, Contraindications, and Monitoring
Possible effects include sleepiness, dizziness, impaired coordination, breast tenderness, bloating, fluid retention, headache, mood changes, spotting, withdrawal bleeding, irregular bleeding, and rare allergic reactions. Some capsule formulations contain peanut oil and require product-specific review.
Because oral micronized progesterone may cause drowsiness, it is commonly taken at bedtime. Patients should be cautious with driving, alcohol, sedatives, or other medications that increase impairment until they know how they respond.
Hormone therapy decisions should account for unexplained vaginal bleeding, prior hormone-sensitive cancer, thromboembolic or cardiovascular history, liver disease, pregnancy potential, and interacting medications. Risks depend on the complete estrogen-progestogen regimen, not progesterone in isolation.
Alternatives for Endometrial Protection
Depending on the clinical situation, alternatives may include an FDA-approved combined estrogen-progestin product, a levonorgestrel-releasing intrauterine system used in an appropriate patient, or another progestin regimen. Choice depends on evidence, bleeding goals, contraception needs, tolerance, cost, and preference.
A saliva hormone test, symptom score, or arbitrary target progesterone level should not replace evaluation of the actual estrogen regimen and whether the progestogen dose provides established uterine protection.
Frequently Asked Questions
Do I need progesterone if I use estrogen?
If you have a uterus and use systemic estrogen, usually yes. Standard low-dose vaginal estrogen used only for genitourinary symptoms generally does not require a progestogen, although individual evaluation still matters.
Do I need progesterone after hysterectomy?
Usually not for uterine protection because the endometrium has been removed. Special circumstances may change the recommendation.
Is progesterone cream equivalent to an oral capsule?
No. Absorption differs, and compounded transdermal products should not be assumed to protect the endometrium reliably.
What bleeding needs evaluation?
Heavy bleeding, persistent irregular bleeding, bleeding after a period of amenorrhea, or any new postmenopausal bleeding should be assessed.
Evidence Resource
Schedule a Consultation
Call 509-392-5007 to schedule your consultation today.
Modern Medical Spa, Richland, WA
Richard Lorenzo, D.O.
